SC Filed 2018-01-16 Event — SEC 0001144204-18-002184 →

Dexxon Holdings Ltd. → Arbutus Biopharma Corp ABUS

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

15 13D/G filings on this issuer

14 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 7.04

16,174,093 shares short · -1.4% vs prior

Other 13D/G Filings on Arbutus Biopharma Corp

Filed	Form	Filer	Stake	Shares
2026-04-13	SCHEDULE 13D/A	Whitefort Capital Management, LP	8.10%	15,794,261	view →
2025-02-25	SCHEDULE	Roivant Sciences Ltd.	20.50%	38,847,462	view →
2025-02-21	SCHEDULE	Whitefort Capital Management, LP	7.00%	13,307,967	view →
2025-02-18	SCHEDULE	Roivant Sciences Ltd.	20.50%	38,847,462	view →
2018-04-23	SC	Roivant Sciences Ltd.	—	—	view →
2018-04-12	SC	Roivant Sciences Ltd.	—	—	view →
2018-03-16	SC	Roivant Sciences Ltd.	—	—	view →
2018-02-14	SC	Roivant Sciences Ltd.	—	—	view →
2018-01-16	SC	QVT Financial LP	—	—	view →
2018-01-16	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2018-01-16	SC	Machado Patrick	—	—	view →
2018-01-16	SC	Lo Andrew	—	—	view →
2018-01-16	SC	SVF Investments (UK) Ltd	—	—	view →
2018-01-16	SC	Roivant Sciences Ltd.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →